FigsharePub Date : 1753-01-01DOI: 10.1021/acsnano.4c06979.s001
Wenjing Liu (552606), Qinying Wang (2805388), Haiyun Luo (5809475), Bichong Luo (19336676), Fujian Zhao (3298539), Yiyuan Kang (5875436), Yanli Zhang (309699), Longquan Shao (5875439)
{"title":"NanographenenOxide Promotes Angiogenesis by RegulatingnOsteoclast Differentiation and Platelet-Derived Growth Factor Secretion","authors":"Wenjing Liu (552606), Qinying Wang (2805388), Haiyun Luo (5809475), Bichong Luo (19336676), Fujian Zhao (3298539), Yiyuan Kang (5875436), Yanli Zhang (309699), Longquan Shao (5875439)","doi":"10.1021/acsnano.4c06979.s001","DOIUrl":"https://doi.org/10.1021/acsnano.4c06979.s001","url":null,"abstract":"An imbalanced system of angiogenesis–osteoblasts–osteoclastsnis regarded as the main factor in bone remodeling dysfunction diseasesnor osseointegration loss. Osteoclast precursors are the key cellsnthat accelerate bone-specific angiogenesis and maintain normal osteoblastnand osteoclast function. Graphene oxide is an effective scaffold surfacenmodification agent with broad application prospects in bone tissuenengineering. However, the effect of graphene oxide on the interactionnbetween osteoclasts and angiogenesis has not yet been elucidated.nIn this study, a rat calvarial defect model was established and treatednwith an electrochemically derived nanographene oxide (ENGO) hydrogel.nHigher angiogenesis and platelet-derived growth factor (PDGF) B innpreosteoclasts were observed in the ENGO group compared with thatnin the control group. Moreover, in vitro experiments demonstrate thenefficacy of ENGO in substantially reducing the expression of the receptornactivator of nuclear factor-kappaB ligand (RANKL)-induced osteoclast-associatednmarkers and inhibiting bone resorption activity. Additionally, ENGOnenhances the secretion of the osteoclast-derived coupling factor PDGF-BBnand promotes angiogenesis. Our investigation revealed the crucialnrole of isocitrate dehydrogenase 1 (IDH1) in the ENGO-mediated regulationnof osteoclast differentiation and PDGF-BB secretion. The decreasednexpression of IDH1 reduces the level of histone lysine demethylasen7A (KDM7A) and subsequently increases the H3K9me2 level in the cathepsinnK promoter region. In summary, we found that ENGO promotes angiogenesisnby inhibiting the maturity of RANKL-induced osteoclasts and enhancingnPDGF-BB secretion. These results indicate that ENGO holds promisenfor the application in fostering osteoclast–endothelial cellncrosstalk, providing an effective strategy for treating bone resorptionnand osteoclast-related bone loss diseases.","PeriodicalId":522358,"journal":{"name":"Figshare","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"1753-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://figshare.com/articles/journal_contribution/Nanographene_Oxide_Promotes_Angiogenesis_by_Regulating_Osteoclast_Differentiation_and_Platelet-Derived_Growth_Factor_Secretion/26502605","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147895819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}